Avalo Therapeutics (NASDAQ:AVTX) Research Coverage Started at Wedbush
Wedbush started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research note released on Friday morning, Marketbeat reports. The firm issued an outperform rating and a $18.00 price target on the stock. AVTX has been the subject of a number of other reports. HC Wainwright assumed coverage on Avalo Therapeutics in […]
Wedbush started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research note released on Friday morning, Marketbeat reports. The firm issued an outperform rating and a $18.00 price target on the stock. AVTX has been the subject of a number of other reports. HC Wainwright assumed coverage on Avalo Therapeutics in […]
